Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06351293 · ClinicalTrials.gov registry record · NA
A Comparative Analysis of Two Hyaluronic Acid Fillers for Nasolabial Fold Correction
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT06351293 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 15 participants.
The verdict
NCT06351293, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a randomized, split-face, subject-blinded, comparative study. Subjects will receive initial treatment with Defyne on one of the NLFs and with RHA3 on the other based on the pre-determined randomization. 4 weeks after the initial treatment, subjects will receive optional touch-up on one side or both sides at the Investigator's discretion for optimal correction. Subjects to return to the site at Month 3, 6, and 12 for follow-ups.
Interventions
- DEVICE Defyne Treatment in Nasolabial Fold
- DEVICE RHA3 Treatment in Nasolabial Fold
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-02-21 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06351293
The ClinicalTrials.gov registry entry for NCT06351293 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Defyne Treatment in Nasolabial Fold is the first listed.
NCT06351293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06351293 about?
NCT06351293 is a clinical study titled "A Comparative Analysis of Two Hyaluronic Acid Fillers for Nasolabial Fold Correction". This is a randomized, split-face, subject-blinded, comparative study. Subjects will receive initial treatment with Defyne on one of the NLFs and with RHA3 on the other based on the pre-determined randomization. 4 weeks after the initial treatment, subjects will receive optional touch-up on one side...
What is the current status of trial NCT06351293?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2024-02-21. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT06351293?
The interventions under investigation include: Defyne Treatment in Nasolabial Fold (DEVICE), RHA3 Treatment in Nasolabial Fold (DEVICE).
Who is sponsoring clinical trial NCT06351293?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.